United States v. Smith & Nephew, Inc.

749 F. Supp. 2d 773, 2010 U.S. Dist. LEXIS 118493, 2010 WL 4365467
District Court, W.D. Tennessee·Decided November 4, 2010·No. Case 08-2832·Published·Cited by 5 cases

Opinion

ORDER DENYING DEFENDANT SMITH & NEPHEW, INC.’S MOTION TO DISMISS

BERNICE BOUIE DONALD, District Judge.

Before the Court is Defendant Smith & Nephew, Inc.’s (“Smith & Nephew”) April 13, 2010 Motion to Dismiss for lack of subject matter jurisdiction and failure to state a claim. (D.E. # 18.) On June 16, 2010, Plaintiff-Relator Samuel Adam Cox, III (“Relator”) filed a response in opposition. With leave of the Court, Smith & Nephew filed a reply on June 29, 2010. For the reasons stated herein, the Court DENIES Smith & Nephew’s motion to dismiss.

I. BACKGROUND

A. Overview

On December 1, 2008, Relator filed this qui tam action on behalf of the United States government against Smith & Nephew under the Federal False Claims Act (“False Claims Act,” “FCA,” or “Act”), 31 U.S.C. §§ 3729 et seq., in the United States District Court for the Western District of Tennessee. Relator filed his complaint under seal pursuant to 31 U.S.C. § 3730(b)(2), which requires FCA relators to file their initial complaints under seal and serve the United States government in accordance with Rule 4(d)(4) of the Federal Rules of Civil Procedure. 31 U.S.C. § 3730(b)(2). After the United States notified the Court pursuant to 31 U.S.C. § 3730(b)(4)(B) that it declined to intervene in this litigation, the Court, by order dated February 11, 2010, unsealed Relator’s complaint and directed Relator to effect service of process on Smith & Nephew. The next day Relator filed an amended complaint. Relator’s amended complaint seeks relief under the FCA both as the Act was written at the time of his employment with Smith & Nephew and as *776 subsequently amended by the Fraud Enforcement Recovery Act (“FERA”) signed into law on May 20, 2009.

B. Allegations of Relator’s Amended Complaint 1

According to Relator’s amended complaint, Smith & Nephew is a British medical devices company with its headquarters in London, England that has sold medical devices to the United States government since at least 2002. (Pl.’s Am. Compl. ¶ 14.) Relator alleges that he worked in Smith & Nephew’s Tennessee office as the company’s Information Technology Global Director of Enterprise Resource Planning from mid-December 2007 until his termination in September 2008 and that in this capacity he learned that Smith & Nephew repeatedly sold and continues to sell products to the United States government in violation of federal procurement law— namely, the Federal Trade Agreements Act — by misrepresenting the items’ country of manufacture. (Id. ¶¶ 12-13, 15.) Under the Federal Trade Agreements Act (“TAA”), 19 U.S.C. § 2502 et seq., the federal government is generally limited when making purchases in excess of a specified amount to products manufactured in the United States or in certain designated countries. See 19 U.S.C. §§ 2503, 2511. Relator contends that Smith & Nephew has violated and continues to violate the TAA by selling the United States government — in an amount exceeding the threshold for TAA applicability — products that were neither manufactured or “substantially transformed” 2 in the United States nor listed as “eligible products” manufactured or “substantially transformed” in one of the “designated countries” from which the federal government may also acquire products.

To this end, Relator identifies two contracts under which Smith & Nephew has made illegal sales. The first is contract Number V797P-4403a by which Smith & Nephew was marketing 7,975 products to the Department of Veterans Affairs (“VA”) as of January 20, 2010, and the other is the General Services Administration’s (“GSA”) Multiple Awards Schedule by which Smith & Nephew was marketing 7,801 products as of January 20, 2010 under contract Number V797P-4403A. (Id. ¶¶ 28, 30-31.) Relator alleges that these products are listed for sale to the government on either the VA’s internet-based MedSurg NonPharmaceutieal Catalogue or the GSA’s Advantage website and that all of these products are either expressly labeled as made in the United States — the case with the products listed on GSA Advantage — or required to comply with the TAA — -the case with the VA’s catalogue. (Id. ¶¶ 32-33.) According to Relator, Smith & Nephew regularly purchases at least 107 of the products on the VA and GSA websites from Straits Orthopaedics, a Malaysian medical device manufacturer, even though Malaysia is not a designated country under the TAA. (Id. ¶ 34); see id. ¶ 35 (citing Ex. 5 at 15 to Pl.’s Am. Compl. (VA document listing designated countries).)

Free access — add to your briefcase to read the full text and ask questions with AI

United States v. Smith & Nephew, Inc., 749 F. Supp. 2d 773, 2010 U.S. Dist. LEXIS 118493, 2010 WL 4365467 (W.D. Tenn. 2010).

749 F. Supp. 2d 773 (United States v. Smith & Nephew, Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related